Accrol Group
Accrol Group Holdings

Accrol Group Holdings share price, company news, analysis and interviews

Accrol Group Holdings plc (LON:ACRL) is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissue and biodegradable wet wipes.

The UK soft tissue market is worth ÂŁ1.6bn with private label products comprising circa 50%. Accrol is the leading supplier to the private label market, which is growing at over 8% year on year.

Opportunity

Accrol is the largest independent supplier of private label toilet roll and kitchen towel in the UK, supplying three of the top four retailers and all the major discounters.

With the largest range of customers in the UK, Accrol is in a unique position to benefit from this ongoing change in consumer buying habits. This broad customer base also gives insight across all consumer purchasing channels, allowing the Group to monitor buying patterns and react quickly to changing consumer trends.

Innovation

Understanding the consumer is key. A good example of Accrol’s ability to react to market demand is the launch of the new “Oceans” plastic free range. Accrol is the first tissue converter to offer a completely plastic free tissue product. The Group has teamed up with the Marine Conservation Society to offer proven products, in plastic free packaging, giving the consumer choice. The product is priced at a level between private label and branded products, ensuring that the consumer is still able to save money whilst making a more environmentally friendly choice.

Accrol Group Holdings plc
Accrol Group Holdings plc

Share this page

Twitter
LinkedIn
Facebook
Email
WhatsApp
Accrol Group

Accrol Group Holdings share price

Fundamentals

52 Week High / Low

News

Interviews

Accrol Group Holdings To Maximise Medium Term Tangible Shareholder Returns (VIDEO)

Accrol Group Holdings plc (LON:ACRL) CEO Gareth Jenkins joins DirectorsTalk Interviews to discuss a trading update ahead of its Half Year Results for the six months ended 31 October 2023.

Having stated in a Strategic Review that the Group aims to maximise medium term tangible shareholder returns, through a combination of dividends and, potentially, share buybacks Gareth explains what he will do with the cash, gives us an idea of potential acquisitions, how the deal with Lifebuoy is progressing, should we expect any others and how the plastics free brand, Oceans is performing.

https://vimeo.com/887315853

Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable wet wipes.

Read More »

Accrol Group Holdings Increased market share, revenues and spare capacity (VIDEO)

Accrol Group Holdings (LON:ACRL) CEO Gareth Jenkins joins DirectorsTalk Interviews to discuss a trading update ahead of its Final Results for the year ended 30 April 2023.

Gareth explains what pleased him most from the statement, what he feels they are doing right to increase market share, what further investment is needed over the next 3 to 5 years, spare capacity to grow, why he is excited about the wet wipe business and how the future looks for the company.

https://vimeo.com/827911954

Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable wet wipes.

Read More »

Accrol Group Holdings CEO Gareth Jenkins ‘deal a successful validation of strategy’ (VIDEO)

Accrol Group Holdings Plc (LON:ACRL) CEO Gareth Jenkins joins DirectorsTalk Interviews to discuss an agreement with one of the world’s largest consumer goods companies Unilever plc (LON:ULVR).

https://vimeo.com/806691163

Gareth explains what this agreement entails, how this deal is a successful validation of its strategy, demand for products, the outlook for the company and what investors should look out for over the coming year.

Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable wet wipes.

The Board believes that, following significant investment over the last four years, Accrol is now the lowest cost tissue-products manufacturer in the UK. This operational efficiency is expected to deliver Lifebuoy kitchen towel at a retail price-point positioned between the current market leader and its private label equivalents, demonstrating exceptional value and quality from a trusted global brand.

Unilever plc is a British multinational consumer goods company with headquarters in London, England.

Established over 100 years ago, they are one of the world’s largest consumer goods companies. Known for great brands and a belief that doing business the right way drives superior performance.

Read More »

Question & Answers

Accrol Group Holdings plc

Accrol Group well positioned & delivering on promises (LON:ACRL)

Accrol Group Holdings plc (LON:ACRL) Chief Executive Officer Gareth Jenkins caught up with DirectorsTalk for an exclusive interview to discuss the post-close statement, growing market share & volume, further investment, space capacity to grow, the John Dale wet wipe business, and what the future looks like for the group.

Q1: Gareth, final results are scheduled to be released in late September, what pleases you most about the post-close statement?

A1: I think the most exciting bit about it really is that Accrol Group delivered what we said we’re going to do. We upgraded our numbers in late December ’22, and we’re really pleased to report that our revenue is higher than we expected.

Quite simply, we’ve delivered on all the promises that we gave our shareholders at the beginning of the year, despite some really challenging times in the last 12 months.

So, we’re just pleased with delivering on our promises.

Q2: You’ve gained further market share this year, not to 21.5%, and you’ve grown volume by almost 8%, what do you feel that you’re getting right?

A2: Over the last 5 years, we’ve seen our market share grow from probably around 8% to now, as you said, just under 22% this year. Certainly, over the last 12 months we’ve listed to the retailers, we’ve listened to what consumers have been saying and we know we’re now getting the right products in front of the individuals.

For toilet tissue, it’s all around softness and we’re one of the market leaders in the sector there. With kitchen towel, it’s on absorbency, and again we compete head-to-head with the brand leaders on performance.

So, it’s about getting the right product to the right consumer, and clearly, we feel we’re getting that right now.

Q3: You’ve spent, over the last few years, about £20 million on capital investment in the business, what else is needed in the next 3-5 years?

A3: In the core business, very little. There’ll be maintenance capital of around £3 million per year but really quite modest investment for the business going forward.

As you’ve said, we’ve spent a great deal of money. We’ve put the business in an incredibly strong position and all our sites are fully automated, all with state of the art machinery.

So, we’re in a really strong position to take advantage of what’s happening in the market.

Q4: How much spare capacity do you have to grow into?

A4: So, the business has about 20-25% spare capacity as we stand today., so more than enough for the next 2-3 years. We’ve worked really hard investing in the right areas to give us that additional headroom and we’re very confident that our growth projections that we’ve got in the marketplace.

We will continue to deliver on those, and we’ve certainly got the machinery and the capacity to do that so we’re in a really good space.

Q5: How excited are you about the wet wipe business, and can you tell us more about that part of the business?

A5: We bought John Dale just under 2 years ago and we bought that business because it was capable of producing biodegradable, water industry approved, flushable wet wipes, turning over in wet wipe volume then of around £2 million. We’ve made some relatively modest investments so far, but we plan to put a further machine into the business.

What I’m really pleased about is the reaction from retailers so we’ve brought to them some new products, all of them are water industry approved, flushable wipes. All of them are plastic-free and we’ve seen a real dramatic increase in revenues in this part of our business, current run rates are over £10 million.

So, we’re really excited about what we can achieve and the capacity, once this new machine comes online, will give us around about £40 million of the revenue. It’s an exciting part of our business, it’s growing very strongly and I’m looking forward to seeing how it progresses over the next couple of years.

Q6: Finally, what does the future look like for Accrol Group?

A6: Good. We’re well positioned going into next year, volumes continue to track where we expect and the business is really well invested.

We’re seeing a real market shift towards private label products as the cost of living crisis impacts individuals, people looking for real value on the shelf for an everyday product like toilet roll or kitchen towel.

We’re really well positioned to take advantage of that so we’re really excited about next year and beyond.

Read More »
Accrol Group Holdings plc

Accrol Group Unilever deal a step change in UK positioning (LON:ACRL)

Accrol Group Holdings plc (LON:ACRL) Chief Executive Officer Gareth Jenkins caught up with DirectorsTalk to discuss their agreement with Unilever, validation of strategy, how the deal will contribute to the overall success of the business, outlook and what investors should be looking out for.

Q1: Gareth, straight to the point, the agreement with Unilever plc (LON:ULVR), you must be thrilled with the deal. Can you just update listeners on what this incredible agreement entails?

A1: As you say, we’re really really pleased with the agreement we’ve set up with Unilever.

What it allows us to do is to produce, under licence, a kitchen towel product under the Lifebuoy brand range, and clearly that then allows us to enter the UK retail and grocery market with a market-leading, well known global brand, manufactured here in the UK.

So, we’re really really pleased about the opportunity this new agreement with Unilever gives us.

Q2: Now, you’ve made an enormous investment in the business over the last 4 years. Do you see this deal as a successful validation of your strategy?

A2: I think we do, we’ve spent almost £20 million over the last 4/5 years in new machinery, fully automating all of our sites.

Clearly, the confidence that Unilever had in us delivering this type of product for them is absolutely a real endorsement of the work that many people in Accrol Group have been working on over the past 5 years. It really marks a real step change for the group in how it’s positioned in the UK.

So, absolutely, we’re really pleased with the endorsement from Unilever.

Q3: This is your first licensing deal and it’s a major success story, how do you see this licensed business model approach contributing to sales and the overall success of the business?

A3: We’ve said already that we see this part of our business growing quite considerably, we’re in discussion with a number of different parties on other potential licencing agreements that we could bring to market.

We see this as being around about 20% of our business in the future so it’s a real important part of our business and the reaction that we’ve had from retailers, as we’ve taken the Lifebuoy product to them, has been fantastic.

So, we’re really excited about what a difference it will make to the group going forward.

Q4: Given the cost pressures consumers and retailers are under, do you see the drivers of demand for your products continuing and how do you view the outlook?

A4: I think with regard to the agreement we’ve got with Unilever and Lifebuoy, we see this positioning really nicely in the market, slightly above our private label product, in price point, but significantly lower than the traditional brand.

The reason why we’re able to bring that to market, at such a competitive price, is the low cost base that Accrol Group has positioned itself and the investment that we’ve made over the last 5 years.

So, we see this giving people a real alternative if someone wants a brand at very competitive price then they’ve now got an alternative. The reality about our products is they are clearly everyday items, they are items that people can’t live without and what we’ve got to make sure is we bring options for all consumers in the UK, no matter what their price point is.

Q5: Finally, what should investors be looking our for in terms of news flow over the coming year?

A5: Our year-end finishes at the end of April, we will give a post-close statement quite soon after that with some more updates that we’ll give to the market in regard to our mill investment that we announced in our half-year results. We’ll also update the market in Q1 of next year so from May/June/July onwards, we’ll give a further update around the mill, and our full-year results will be due out around September of this year.

So, quite a lot of information coming out but a really exciting time for the group.

Read More »
Accrol Group Holdings plc

Accrol Group well positioned to take advantage of significant changes in the marketplace (LON:ACRL)

Accrol Group Holdings plc (LON:ACRL) Chief Executive Officer Gareth Jenkins and Chief Financial Officer Richard Newman caught up with DirectorsTalk for an exclusive interview to discuss what’s driven progress & market share growth, their ability to pass on cost inflation to customers, key priorities for the business going into FY23 and the outlook for the company going forward.

Q1: First off, Gareth, you must be very pleased with your FY22 results, but what’s driven the progress, and the growth in market share in particular?

A1: We’re really pleased with the results that we announced earlier on in the week. The key part really has been the work that’s gone on over particularly the last two years with the amount of investments going to the organisation. We’ve now fully automated all of our factories in their entirety, the bulk of all of our investments is now behind us and we have some modest amount of capital spend going forward.

The business now is transformed an organisation. We’re now the lowest cost producer in the UK of toilet roll and kitchen towel, we’ve got a very strong position with all of the retailers and discounters in the UK, and the product range that we’ve got is incredibly strong, delivering a range of products for every consumer in the UK, no matter what your price point.

That’s helped us enormously in growing our market share. The business this year has grown around 17%, we’re really, really pleased with that growth but more importantly, we’ve also been able to pass through significant price increases from our input costs, which have really been driven by energy cost changes. That’s on the back of the quality of the products that we’re able to deliver to the retailers and then onto the consumers.

So, really pleased with the results and we’re really excited about progress for this year as well.

Q2: Richard, we’re in unprecedented periods with cost inflation and so on. What’s your ability to pass on through to customers and are you pulling any other levers to manage the cost base?

A2: Yes, it’s certainly been unprecedented times, I don’t think either me or Gareth have ever seen an environment quite like it.

We’ve faced very significant cost headwinds driven by, as Gareth said, energy, but other factors, the cost of pulp, the cost of haulage, the cost of shipping containers, the cost of other materials that we use in our products. So, on an annualised basis, we’ve faced headwinds of over ÂŁ70 million and we have been successful in passing that cost on to our retail customers through a series of price increases during the year. They’ve been challenging conversations as you might have imagined, quite rightly given the scale of those increases. Our customers have been extremely supportive, they understand what’s driving those cost increases and so we’ve been able to pass them on.

Internally though, we’re always aware that we need to be as efficient as possible so we’re always looking for ways to become more efficient. We’ve saved another ÂŁ3 million internally from our own cost initiatives, some of those have been driven by synergies from the acquisitions we made over 12 months ago.

So, we bought the Leicester Tissue Company and the John Dale wet wipes business over 12 months ago, and we’ve generated synergy benefits from that. We’ve also continued to invest in the business so we’ve now got fully automated facilities in our Blackburn site, in our Leyland manufacturing site as well, and again, those investments and that automation has driven cost out of our business as well.

We continually focus on bringing our own cost base down, but the scale of the input cost rises meant that we had to put through very significant price increases but they were achieved during the year.

Q3: Gareth, looking ahead to FY23, is the strategic review continuing? What are the key priorities for the business?

A3: The review is ongoing and I’ll come to that in a moment, but I think as we look forward to FY23, there’s been some quite significant changes in the marketplace which put Accrol Group in a very strong position. Because of the inflationary pressures that are impacting the UK, the consumer clearly now has some choices to make around the everyday products that we produce.

We’ve seen the marked change in market share, the private label now commands around 54% of the UK spend with brands declining to 46%. In the first quarter of this year, private label grew by around 10%, Accrol grew 28% in the same period and, as Richard said, that’s on the back significant investment we’ve made, the full automation of our factories and the product range that we’ve got is second to none.

So, part of that strategic review has been the company’s position in the marketplace. We’re really well positioned as a group, we have a third of the UK private label market and around 20% of the total market so we are a major player in the UK.

Part of the strategic review is around our mill development. We are ready to go with the machine specification, the building design is complete, and the location of where we want to put the mill is progressing well. Part of the delay for us has been around building costs, they have risen dramatically during this period, something that we’re seeing starting to soften so once the conditions are right for us to progress with the mill development, we will do that.

We’ve already said to our shareholders and to the market that we will fully update everyone in early ’23 but the business is now incredibly well positioned to take advantage of a significant change in the marketplace going forward.

So, we are really pleased with where we’re up to and excited about the future.

Q4: Finally, what’s the outlook like for Accrol Group in FY23, and why should investors follow you?

A4: Well, as I I touched on earlier actually, the dynamic of the market is changing rapidly. If I go back just three months, the market share between private label and brands was 50/50 and as I said earlier, it’s now 54% in favour of private label. We only see that accelerating as people get more pressure with where they spend their money, they want to look for an everyday product that we produce that gives them the right value.

The range that we’ve now got, we’ve introduced our own tertiary brands so we’ve got the fastest-growing brand in kitchen towel with Magnum, we’ve got one of the biggest growing toilet roll brands behind Andrex in our Elegance range, which is now in 30,000 convenient stores in the UK. As Richard mentioned, our flushable wet wipe business, that’s grown from ÂŁ2 million annualised sale to a run rate today of ÂŁ6 million in the first 12 months, we’re really excited about. We have a range of products there that are water industry approved and then our state of the art facial tissue business that was fully automated in the year, again, we see some significant growth in that market for us.

So, we’re well positioned, we believe that investors have got an opportunity of getting involved in the Accrol story. We know that we are a market leader and there’s some big advantages coming our way as the market changes quite dramatically over the next 12 months so we’re looking forward to it.

Read More »

Analyst Notes & Comments

Accrol Group Holdings plc

Accrol Group Holdings Consecutive Upgrades and Positive Trading Momentum say Zeus Capital

Accrol Group Holdings (LON:ACRL) H1 FY24 has delivered positive trading momentum with continued volume growth and an acceleration in margin recovery back to pre-pandemic levels. Zeus Capital confirms that FY24E EBITDA guidance is upgraded once again, with its revised adj. EBITDA forecast of £21.0m 16.7% ahead of the £18.0m they forecast a year ago. Accrol’s strong relationship with retailers and its strengthened supply model leaves it well placed to continue to execute profitable growth.

H1 FY24 trading update: Accrol has released a half year trading update for the six months ended 31 October 2023 (H1 FY24) confirming positive trading and an upgrade to FY24E profitability. Performance in H1 has been robust, with volume growth continuing throughout the period, and margins returning to pre-pandemic levels more quickly than previously forecast, driven by higher sales volumes, positive business mix and operating efficiencies. CEO Gareth Jenkins said “We are clearly very pleased with this performance. We continue to deliver by having great quality and value products which meet every consumers budget. Our strong relationship with the retailers and our robust supply model are ensuring we can continue to deliver a strong set of results in a changing market environment.” Interim results are scheduled for release in late January 2024.

Profitability upgraded for the second time in two months: Management now expect FY24E adjusted EBITDA to be “at least £21.0m”. This is the Group’s second upgrade to guidance in as many months, following the 6.0% increase to our FY24E adjusted EBITDA forecasts (from £18.8m to £19.3m) published on 26 September and is 16.7% ahead of the £18.0m FY24E adjusted EBITDA we forecast a year ago. Consecutive upgrades to profitability reflect the Group’s robust market position, strong customer relationships, positive trading momentum and tight control of costs. This is an impressive performance versus the wider consumer backdrop over the past 12 months.

Forecasts: FY24E revenue is unchanged from our last published forecasts (26 September) at £205.0m. FY24E gross margin is increased 25 basis points to 24.5%, reflecting margins returning to pre-pandemic levels faster than anticipated. This improvement in gross margin reflects the Group’s strong customer relationships and tight cost control. Increased gross margin drives a 2.5% or £0.5m increase in our adjusted EBITDA forecast to £21.0m, in line with revised company guidance of “at least £21.0m”. We leave our interest and tax assumptions unchanged, with adjusted PBT 4.5% higher at £12.0m, driving a 4.5% upgrade to adjusted EPS of 2.8p per share. FY24 Adjusted net debt (excluding lease liabilities) of £20.3m
is left unchanged, in line with management expectations of c.1.0x EBITDA. This is a notable improvement on the 1.7x and 3.0x leverage reported at the FY23A and FY22A year ends respectively, driven by improved profitability and a step down in capex following the conclusion of capital investment in automation of the core tissue line in FY23. FY25E forecasts are unchanged.

The Group’s planned paper mill continues to progress and should be operational by mid-2025. A vertically integrated paper mill will reduce volatility in tissue input costs, give security and visibility of supply, further waste efficiency gains and deliver material earnings accretion within its first full year of operations.

Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable wet wipes.

Read More »
Accrol Group Holdings plc

Accrol Group: two EBITDA upgrades and earnings tailwinds praised by Shore Capital (LON:ACRL)

Accrol Group Holdings plc (LON:ACRL) is the topic of conversation when DirectorsTalk Interviews caught up with Tom Fraine, Equity Research Analyst – Industrials at Shore Capital. We asked:

  1. What were the highlights of Accrol’s H1 update?

The news on margins returning to pre-pandemic levels quicker than anticipated was the key highlight. We were very pleased to put through a second upgrade to EBITDA in as many months. This is a clear indication to us that expectations are being managed conservatively and reflects management’s well-executed plan to invest in automated production, which has helped the Company become the lowest cost player in the UK market. 

  1. How do you the view the outlook for Accrol as a result of their transformational automation programme?

We anticipate strong cash generation and forecast >£13m free cash flow for FY24F, implying a 13% FCF yield, following the completion of the programme. Capex is set to more than halve in FY24F and should remain low in the medium term, as the Group has 20% excess production capacity to support continued volume growth. Stabilising input costs and market conditions, discount grocers’ market share gains and growth in private label sales are all clear tailwinds for earnings. The prospect of vertical integration from a highly accretive, self-funded investment in a paper mill is likely, in our view, to drive a further material increase in the Group’s margins after becoming operational, expected in mid FY25F.

  1. How do you see Accrol in terms of fair value?  

Our 50p DCF-based fair value indicates close to 60% upside. The free cash flow yield is very attractive, in our view.

Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable wet wipes.

Read More »

More Information

Latest Accrol Group Holdings News

Interviews

Questions & Answers

Broker Notes & Comments

Accrol Group Holdings share price

Fundamentals

Share this page

Twitter
LinkedIn
Facebook
Email
WhatsApp

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.